Interleukin-7 (IL-7) treatment accelerates neutrophil recruitment through gamma delta T-cell IL-17 production in a murine model of sepsis. - Wikidata - wikimedia - TriplyDB

Interleukin-7 (IL-7) treatment accelerates neutrophil recruitment through gamma delta T-cell IL-17 production in a murine model of sepsis.

Interleukin-7 (IL-7) treatment accelerates neutrophil recruitment through gamma delta T-cell IL-17 production in a murine model of sepsis.

http://www.wikidata.org/entity/Q34290886

about

The coagulopathy of acute sepsis Clinical review: sepsis and septic shock--the potential of gene arrays Genomic expression analyses reveal lysosomal, innate immunity proteins, as disease correlates in murine models of a lysosomal storage disorder Immunosuppression after sepsis: systemic inflammation and sepsis induce a loss of naïve T-cells but no enduring cell-autonomous defects in T-cell function Amitriptyline Usage Exacerbates the Immune Suppression Following Burn Injury Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis Reduced plasma levels of soluble interleukin-7 receptor during graft-versus-host disease (GVHD) in children and adults.Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.Burn wound γδ T-cells support a Th2 and Th17 immune response Role of circulating lymphocytes in patients with sepsis.A historical perspective on sepsis.Burn induces a Th-17 inflammatory response at the injury site.Neonatal sepsis and inflammatory mediators.Interleukin-7 and anti-programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression.Murine IL-17+ Vγ4 T lymphocytes accumulate in the lungs and play a protective role during severe sepsis Regulation of lymphocyte trafficking by CXC chemokine receptor 3 during septic shock Clinical review: flow cytometry perspectives in the ICU - from diagnosis of infection to monitoring of injury-induced immune dysfunctions.High-dose ascorbate with low-dose amphotericin B attenuates severity of disease in a model of the reappearance of candidemia during sepsis in the mouse.Interleukin-7 ameliorates immune dysfunction and improves survival in a 2-hit model of fungal sepsis.T cells from patients with Candida sepsis display a suppressive immunophenotype Early IL-17 production by intrahepatic T cells is important for adaptive immune responses in viral hepatitis Current trends in inflammatory and immunomodulatory mediators in sepsis Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer?Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding.Respective IL-17A production by γδ T and Th17 cells and its implication in host defense against chlamydial lung infection.Harnessing the biology of IL-7 for therapeutic application.The immune response to severe bacterial infections: consequences for therapy.Cytokine control of inflammation and repair in the pathology of multiple sclerosis.The Role of Adjunctive Therapies in Septic Shock by Gram Negative MDR/XDR Infections.Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression.Apoptosis-induced lymphopenia in sepsis and other severe injuries.Elevated plasmatic level of soluble IL-7 receptor is associated with increased mortality in septic shock patients.Dying to protect: cell death and the control of T-cell homeostasis.IL-7 and procalcitonin are useful biomarkers in the comprehensive evaluation of the severity of acute cholangitis.Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of Pseudomonas aeruginosa pneumonia.Modulation of Interleukins in Sepsis-Associated Clotting Disorders: Interplay With Hemostatic Derangement.Thymic Stromal Lymphopoietin Improves Survival and Reduces Inflammation in Sepsis.A Murine Model of Persistent Inflammation, Immune Suppression, and Catabolism Syndrome Imaging Apoptosis in Sepsis--A Technology We Would Die for!

P2860

Q26826950-9D54AC06-436A-4250-A64C-342274F66D7A Q26864138-682CDFBE-0F58-4C52-B9AD-71F1B8A02390 Q27312396-8588483E-703E-480E-AAD4-B5188BF61282 Q27320494-5465681D-E26B-4C17-863E-C46A80D1008B Q30370188-27A3ABF6-C31B-4BB8-B0F6-6FD23261EAC5 Q33749945-E44BF186-5615-4D69-A5B8-DA1C54DD8FB0 Q33817588-D4AE9732-0133-49B2-863C-89D39298633E Q33828888-D9552C71-B423-4485-9550-E62F51D9A1AE Q33902749-A4B45948-6839-4E42-90DE-2E7BB16ED034 Q34177314-E726E36F-B67A-4189-8806-493422AF0183 Q34277875-4331E850-6562-43DE-9A10-636D48843A4F Q34843643-C6EB8735-F366-49B3-BE46-AFF188402C80 Q34970523-2B8E7181-E958-4B47-90A0-EC15AABB8A77 Q35177535-467A1B4C-E9A3-4860-9BD9-0418ED958FCC Q35650392-6619E180-DCFC-4FD2-8AF8-98977B645A16 Q35813689-F9BEE5EA-0D70-433E-A44A-E0790EAFEF10 Q35908002-43F6AA02-1AC6-4544-A258-44D6B857FDD8 Q35917505-2D912580-D90C-4258-AE33-A510EF9AD698 Q36379309-DBF40D69-0EB5-45D9-9DF2-0F4B4CE9E33C Q36480729-4CB8438B-5BD6-4841-8621-5005E26CEE8E Q36514100-45D23ECA-4A96-426C-979E-4EEAEF5EDC0D Q36628592-2380A50B-2944-4A12-8878-02D6E2124432 Q37233354-B8932417-18E1-4ADB-8BD5-87BC6BDCDD77 Q37563023-CA652C8B-7A26-4E2F-BB29-DA0758414908 Q37655890-B49A1F0C-51DB-4196-8BC0-2C5509C60557 Q37835446-BBA836A4-4A89-4E0B-9D9D-6D6D90FB53E2 Q37867487-93E1FEC0-4EA3-4245-A9D4-EE5224A21EAA Q37991392-6E364D39-6EC1-4B17-8967-B7AF124AA7D2 Q38067389-F57B3F3A-CC6F-4798-B88B-BC1DE240826B Q38642048-338051A1-11D2-405D-AEC3-D2EE001EF41B Q38836832-1472BCB5-D4B6-4C9D-AE26-E19FFD8A08D2 Q38998292-E8E00D79-7D1D-4CCB-9F6E-659E7FD3F155 Q39170358-871BB007-1C1E-4F37-858B-65244194B70A Q39277476-6760A17A-F529-4892-A3C1-859206F9EE57 Q40400275-11BB7FEC-78E5-4F30-B8FC-DD0103B737E8 Q40539825-45DFB5B0-0DFD-43C1-91DE-4C5F7E1D0AE0 Q40602826-227F5F89-BCE8-4659-A839-8DC7417CB4B8 Q40770616-8B8BF928-D13B-4959-8408-1281453E2E41 Q41574040-65802F99-6516-4435-AE25-1C0EA9D90D87 Q42873085-B23A3C43-3332-408C-8927-3B5F40F197A0

P2860

Interleukin-7 (IL-7) treatment accelerates neutrophil recruitment through gamma delta T-cell IL-17 production in a murine model of sepsis.

http://www.wikidata.org/entity/Q34290886

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Interleukin-7 (IL-7) treatment ...... n in a murine model of sepsis.

@ast

Interleukin-7 (IL-7) treatment ...... n in a murine model of sepsis.

@en

type

label

Interleukin-7 (IL-7) treatment ...... n in a murine model of sepsis.

@ast

Interleukin-7 (IL-7) treatment ...... n in a murine model of sepsis.

@en

prefLabel

Interleukin-7 (IL-7) treatment ...... n in a murine model of sepsis.

@ast

Interleukin-7 (IL-7) treatment ...... n in a murine model of sepsis.

@en

P1433

Q34290886-C5B04829-53EE-49A4-9FFC-21FEB538B4FC

P1476

Q34290886-EC8528C4-B526-4B82-BD82-E755200CDD65

P2093

Q34290886-28F04361-A694-4DDC-9470-AE33A8D5E87F

Q34290886-6614801B-03DB-4BAE-885A-1169078C9782

Q34290886-95683FA9-766E-4197-8C41-DE130500F4D4

Q34290886-9B4AF247-B5BD-4C9F-9EBC-99F4B24BF4E9

Q34290886-AE2B2754-03EF-4FD1-918C-EC7D3695AFEB

Q34290886-AFC8430C-747B-4C51-B1A9-B0D473D4AAE4

Q34290886-D5364975-ABE8-4907-9C88-DD3330E808CF

Q34290886-F8787CE2-DF11-48FB-88EF-6DE2622DDAD4

P2860

Q34290886-03DF385F-082C-4CFD-BD76-80223C7EF19C

Q34290886-084D2183-32A6-45F9-A345-F4E148AEEACE

Q34290886-0B139DBD-C5E5-4746-9D28-1AC7AC0D024A

Q34290886-0CF20658-5DAB-4CD1-8090-E33D0C3A8DB7

Q34290886-0DBE0497-A5F7-492C-94E0-97552BC36386

Q34290886-111EDB00-A22C-42B5-A554-DE6D008AD1F2

Q34290886-119C7EC5-4A20-4A31-BD4E-5EA64F8F1750

Q34290886-11B1F3B7-9CCC-409A-90EE-422DBDB9C9C7

Q34290886-1C4073D5-61C1-4D68-A975-45AE95A1DC46

Q34290886-203F2148-D5C8-4FB3-BABB-273630771F0E

P304

Q34290886-F255014C-F3BD-44B8-B892-1D5E2BE42D2A

P31

Q34290886-A2D34661-465A-4F68-9ECA-D74B16022D3C

P356

Q34290886-B29260DD-DC42-489F-869A-1E89BB84CB59

P407

Q34290886-D53716CC-DA3F-41A8-B8A7-468A9AC0CA27

P433

Q34290886-8A30F8DB-D50E-4BBC-BE8D-ECDBC889CA75

P478

Q34290886-63CCD687-3997-4E32-89BC-933204831E2A

P50

Q34290886-04708868-E18C-4A2B-AA50-58D1933453A8

Q34290886-0D861277-E8CE-4E6D-9B75-FBFB7BB10B1B

Q34290886-61C5A49E-9EE8-4ADD-B901-0DC03CC13B00

Q34290886-A8F24A06-6ADF-4748-929A-269022DCCB5B

Q34290886-ADCD581E-BC57-48FF-8AB8-62314A4BBF5D

P577

Q34290886-19FFA4A9-F607-49CB-AC4E-AD483CB7C621

P698

Q34290886-97DEE986-717E-4DDD-8FCD-1F588B3CF612

P921

Q34290886-00EBA4C1-A29B-42EF-B047-5CE74003D7D3

P932

Q34290886-FDA36E20-897B-4EEC-B431-D6F74BA20853

P356

P1433

Infection and Immunity

P1476

Interleukin-7 (IL-7) treatment ...... on in a murine model of sepsis

@en

P2093

Aaron P Seitz

http://www.w3.org/2001/XMLSchema#string

Cindy M Cave

http://www.w3.org/2001/XMLSchema#string

Holly S Goetzman

http://www.w3.org/2001/XMLSchema#string

Jacqueline Unsinger

http://www.w3.org/2001/XMLSchema#string

Lisa G England

http://www.w3.org/2001/XMLSchema#string

Michel Morre

http://www.w3.org/2001/XMLSchema#string

Priya S Prakash

http://www.w3.org/2001/XMLSchema#string

Tony T Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells

Structure and signalling in the IL-17 receptor family

T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

Interferon-inducible protein 10, monokine induced by interferon gamma, and interferon-inducible T-cell alpha chemoattractant are produced by thymic epithelial cells and attract T-cell receptor (TCR) alphabeta+ CD8+ single-positive T cells, TCRgammad

IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking

Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis

IL-17 family cytokines and the expanding diversity of effector T cell lineages

Increased granulopoiesis through interleukin-17 and granulocyte colony-stimulating factor in leukocyte adhesion molecule-deficient mice.

P304

4714-4722

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.00456-10

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P50

Charles C. Caldwell

Cristina Mazuski

Richard S Hotchkiss

P577

2010-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20823197

http://www.w3.org/2001/XMLSchema#string

P921

P932

2976361

http://www.w3.org/2001/XMLSchema#string